AtriCure, Inc. (ATRC) vs MBX Biosciences, Inc. Common Stock (MBX)

A side-by-side comparison of AtriCure, Inc. and MBX Biosciences, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
AtriCure, Inc. logo
ATRC
AtriCure, Inc.
$2.78B
$54.73HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT
MBX Biosciences, Inc. Common Stock logo
MBX
MBX Biosciences, Inc. Common Stock
$2.73B
$57.29HealthcareDelayed quote: Oct 6, 2026, 11:24 AM EDT

Total return — ATRC vs MBX

growth of $100 · dividends reinvested · last 2y
ATRC +109.6% (+44.8%/yr)MBX +147.5% (+57.3%/yr)MBX compounded faster over this window
100200300Start $10020252026$210$248
ATRC MBX

ATRC vs MBX: by the numbers

  • •ATRC is the larger company ($2.78B vs $2.73B market cap).
  • •ATRC is profitable (1.85% net margin) while MBX runs a net loss (0.00%).

Metrics side by side

Valuation

MetricATRCMBX
P/E ratio257.89N/A
P/S ratio4.89N/A
P/B ratio5.396.66
EV / EBITDA77.33N/A
FCF yield1.84%N/A

Profitability

MetricATRCMBX
Gross margin76.16%0.00%
Operating margin2.44%0.00%
Net margin1.85%0.00%
ROE2.04%-25.47%
ROIC2.04%-28.60%

Growth (annualized)

MetricATRCMBX
Revenue CAGR (5Y)18.57%N/A
Total return CAGR (5Y)-4.06%N/A

Frequently asked

Is ATRC or MBX more profitable?
ATRC runs the higher net margin — ATRC at 1.85% versus MBX at 0.00%.

Go deeper

Full ATRC analysisFull MBX analysisInteractive comparison tool

Dig into the metrics

AtriCure P/E ratioAtriCure ROEMBX Biosciences, Inc. Common Stock ROEAtriCure operating marginMBX Biosciences, Inc. Common Stock operating marginAtriCure revenue growthMBX Biosciences, Inc. Common Stock revenue growthAtriCure free cash flowMBX Biosciences, Inc. Common Stock free cash flow

AtriCure & MBX Biosciences, Inc. Common Stock appear in these rankings

Fastest Revenue Growth StocksHighest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.